WebJun 5, 2024 · Central serous chorioretinopathy (CSCR) is a rare side-effect noted following prolonged topical minoxidil therapy for androgenic alopecia. In this report, we describe a case of a 41-year-old young man who developed CSCR following prolonged therapy with topical Minoxidil solution and was treated with oral eplerenone. Case presentation WebThe results suggest that the antioxidant defense system may be inadequate or corrupted in CSCR, and reduced DHEA-S level is one of the factors that trigger this insufficiency. BackgroundThe objective of this work is to evaluate plasma total antioxidant capacity (TAC), total oxidant status (TOS), and dehydroepiandrosterone sulphate (DHEA-S) levels in …
Type one macular neovascularization in central serous ... - Nature
WebChoroidal neovascularization (CNV) is a relatively uncommon sequela of chronic central serous chorioretinopathy (CSCR), with incidence estimates ranging from 2% to 9%. 1-3 Moreover, CNV can be a major cause of … WebMake Waves at the 2024 ASCRS Annual Meeting. What you need to know: • Register by the Tier 2 registration deadline, April 2. • Begin building your schedule with the Real-Time … howard cosell drunk on monday night football
CSR - central serous retinopathy information
WebApr 20, 2024 · Ophthalmologic Manifestations. Several ophthalmologic conditions are associated with OSA, including floppy eyelid syndrome (FES), glaucoma, nonarteritic … WebApr 2, 2013 · The goal of the study is to examine the short-term effects and safety of a systemic anti-aldosterone medication, eplerenone, in a small group of patients with central serous chorioretinopathy (CSCR). There is currently no standard treatment or therapy for either acute or chronic CSCR, a potentially debilitating eye disease. WebFeb 21, 2014 · Central serous chorioretinopathy (CSCR) is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the … how many inches are in a minute